LOGO
LOGO

Article Search

Discover the power of RTTNews website's advanced search page, designed for seamless Article retrieval by Company Name, Stock Symbol, and other criteria.
Stay updated with the Latest News on specific Companies, Financial Insights, and Market Trends. We Ensure you to get the most relevant information instantly.

Symbol  
Company  
Currency Symbol   eg (EUR/USD)
Keyword  
  • Wedbush Is Lowering Sarepta Therapeutics (SRPT) FY 26 Estimate To 3.67 From 4.29 3/26/2026 11:16:59 AM
  • Wedbush Is Lowering Sarepta Therapeutics (SRPT) Q4 26 Estimate To 3.20 From 3.37 3/26/2026 11:16:48 AM
  • Wedbush Is Lowering Sarepta Therapeutics (SRPT) Q3 26 Estimate To 0.12 From 0.27 3/26/2026 11:16:37 AM
  • Wedbush Is Lowering Sarepta Therapeutics (SRPT) Q2 26 Estimate To 0.07 From 0.22 3/26/2026 11:16:29 AM
  • Wedbush Is Cutting Sarepta Therapeutics (SRPT) Q1 26 Estimate To 0.25 From 0.41 3/26/2026 11:16:20 AM
  • Sarepta Announces Promising First Clinical Data From SiRNA Programs Targeting FSHD1 And DM1 3/25/2026 8:14:30 AM
  • Wedbush Is Raising Sarepta Therapeutics (SRPT) FY 26 Rev. Estimate To 1765 M From 1545 M 3/2/2026 8:20:12 AM
  • Wedbush Is Increasing Sarepta Therapeutics (SRPT) Q4 26 Rev. Estimate To 695.8 M From 399.0 M 3/2/2026 8:04:04 AM
  • Wedbush Is Cutting Sarepta Therapeutics (SRPT) Q3 26 Rev. Estimate To 357.5 M From 391.5 M 3/2/2026 8:02:17 AM
  • Wedbush Is Cutting Sarepta Therapeutics (SRPT) Q2 26 Rev. Estimate To 347.6 M From 381.3 M 3/2/2026 8:02:02 AM
  • Wedbush Is Cutting Sarepta Therapeutics (SRPT) Q1 26 Rev. Estimate To 364.4 M From 373.7 M 3/2/2026 8:01:49 AM
  • Wedbush Is Increasing Sarepta Therapeutics (SRPT) FY 26 Estimate To 4.29 From 1.61 3/2/2026 8:01:15 AM
  • Wedbush Is Raising Sarepta Therapeutics (SRPT) Q4 26 Estimate To 3.37 From 0.44 3/2/2026 8:01:06 AM
  • Wedbush Is Lowering Sarepta Therapeutics (SRPT) Q3 26 Estimate To 0.27 From 0.42 3/2/2026 8:00:55 AM
Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us   |   Contact Us   |   Privacy   |   Sitemap